DDR2 and breast cancer: Gonzalez et al. demonstrated in human MSCs isolated from breast cancer metastasis that stromal cells expressing a fibroblastic phenotype were able to upregulate collagen receptor expression, namely discoidin domain receptor 2 (DDR2), in breast cancer cells and increase collagen deposits promoting breast cancer cell alignment, migration, and metastasis [187].